Flavio Mantelli - 21 Jul 2026 Form 4/A - Amendment Insider Report for OKYO Pharma Ltd (OKYO)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: OKYO
Reported as of: 21 Jul 2026
Net transaction value: +$28,000
SEC form: 4/A - Amendment
Accepted by SEC: 07 Aug 2026, 16:15:30 UTC
Original report date: 22 Jul 2026
Prior SEC filing: 17 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Flavio Mantelli

Key filing fact

Flavio Mantelli filed Form 4/A - Amendment for OKYO Pharma Ltd (OKYO) on 07 Aug 2026.

Key facts

This page summarizes Flavio Mantelli's Form 4/A - Amendment filing for OKYO Pharma Ltd (OKYO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Aug 2026, 16:15.

Change

Previous filing in this sequence was filed on 17 Jun 2026.
Current net transaction value: +$28,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002127572 Primary reporting owner

Mantelli Flavio

Relationship: CHIEF MEDICAL OFFICER
Address: 14-15 CONDUIT ST, LONDON, UNITED KINGDOM
Signature: /s/ Flavio Mantelli
Signature date: 07 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OKYO transaction

COMMON STOCK

Purchase

Transaction value: $28,000
Shares: +20,000
Change %
Price: $1.40
Shares after: 20,000
Date: 21 Jul 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

This Form 4/A amends the Form 4 filed on July 22, 2026 solely to correct the transaction code associated with this open market purchase. No other reported transactions are affected by this amendment.